$CNXU

Conexeu Sciences Inc.

Conexeu Sciences develops collagen scaffolds for regenerative tissue applications. Its products include an extracellular matrix scaffold platform and CXU collagen gel, with applications in aesthetics, wound care and tissue repair. The company focuses on uses such as facial rejuvenation and restoring volume in the face, breasts and buttocks. It serves clinicians and other professionals in beauty, aesthetics, regenerative medicine and medical care. Conexeu Sciences is based in Reno, Nevada.

0
1
0

No SEC Form 4 filings for $CNXU in the last 30 days.

See all $CNXU insider activity →
Low

Conexeu Sciences Inc. (CNXU) Develops Two New Wound-Device Formats

Conexeu Sciences Inc. (CNXU) announced early-stage development of two new wound-device formats, W.A.F.E.R. Sheet and Lattice, which have not yet undergone preclinical studies. The company's flowable CXU candidate's FDA 510(k) submission is still targeted for Q1 2027, pending required testing and regulatory processes.

Conexeu Sciences Inc. (CNXU): Unregistered Sales of Equity Securities

Conexeu Sciences Inc. (CNXU) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. CONEXEU SCIENCES INC. LETTER TO SHARE PURCHASE WARRANTHOLDERS October [●], 2026 TO: The registered Holders of Share Purchase Warrants exercisable at US$2.30 per share Conexeu Sciences Inc. (the "Company") HEREBY GIVES NOTICE that a warrant exercise inducement program (the "Induce

Conexeu Sciences Inc. (CNXU): Unregistered Sales of Equity Securities

Conexeu Sciences Inc. (CNXU) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. Item 3.02 Unregistered Sales of Equity Securities From September 14, 2026 through October 15, 2026, Conexeu Sciences Inc. (the "Company") has issued an aggregate of (i) 1,290,000 unregistered shares of common stock, (ii) 1,333,333 units (each, a "Unit"), with each Unit consisting

CNXU sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning CNXU (Conexeu Sciences Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent CNXU coverage spans corporate actions, earnings and technology.

What's driving CNXU

AlphAI scores every news story that mentions CNXU with an AI model for sentiment and relevance, and aggregates insider trades from Conexeu Sciences Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CNXU

Score
$CNXUMedOffering· 4.76M · proposed

Conexeu Sciences Inc. (CNXU): Unregistered Sales of Equity Securities

Conexeu Sciences Inc. (CNXU) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. CONEXEU SCIENCES INC. LETTER TO SHARE PURCHASE WARRANTHOLDERS October [●], 2026 TO: The registered Holders of Share Purchase Warrants exercisable at US$2.30 per share Conexeu Sciences Inc. (the "Company") HEREBY GIVES NOTICE that a warrant exercise inducement program (the "Induce

$CNXUMedOffering· $4M · closed

Conexeu Sciences Inc. (CNXU): Unregistered Sales of Equity Securities

Conexeu Sciences Inc. (CNXU) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. Item 3.02 Unregistered Sales of Equity Securities From September 14, 2026 through October 15, 2026, Conexeu Sciences Inc. (the "Company") has issued an aggregate of (i) 1,290,000 unregistered shares of common stock, (ii) 1,333,333 units (each, a "Unit"), with each Unit consisting

$CNXULowOffering· $1.75M · closed

Conexeu Sciences Inc. (CNXU): Unregistered Sales of Equity Securities

Conexeu Sciences Inc. (CNXU) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. Item 3.02 Unregistered Sales of Equity Securities From June 18, 2026 through September 4, 2026, Conexeu Sciences Inc. (the "Company") has issued an aggregate of 1,448,368 unregistered shares of common stock and 202,500 unregistered common stock purchase warrants pursuant to vario

Related tickers